New Blood-Clot monitor could cut transfusions in heart surgery

NCT ID NCT06328647

Ongoing Disease control Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a bedside device called Quantra can help doctors decide when to give blood transfusions during complex heart surgery. The device measures how well a patient's blood clots in real time. Researchers hope this will reduce the number of blood products (like red cells, plasma, and platelets) given during and right after surgery. The trial involves 666 adults having high-risk heart surgery at the Cleveland Clinic.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Quantra QPlus System (point-of-care device)
What this could lead to: If successful, this could reduce the need for blood transfusions during complex heart surgery, lowering risks and improving recovery.
What could go wrong: This is a single-center trial, and results may not apply to all hospitals. The device may not significantly change transfusion rates compared to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic disorder coronary artery disorder end stage renal failure endocarditis heart failure heart valve disorder Hemorrhage hemorrhagic disease pulmonary embolism vascular hemostatic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLEEDING HEMOSTATIC DISORDER

Contacts and locations

Locations

Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.